8.49MMarket Cap-0.90P/E (TTM)
1.4400High1.3500Low26.97KVolume1.4400Open1.3800Pre Close37.87KTurnover0.61%Turnover RatioLossP/E (Static)6.15MShares3.450052wk High0.28P/B6.07MFloat Cap1.300152wk Low--Dividend TTM4.39MShs Float27279.9864Historical High--Div YieldTTM6.52%Amplitude1.3001Historical Low1.4030Avg Price1Lot Size
Aytu BioPharma Stock Forum
Aytu BioPharma Announces Exclusive Agreement with Lupin Pharma Canada Ltd to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Canada
Once approved by Health Canada, Adzenys and Cotempla will be the only orally disintegrating, extended-release tablets for the treatment of ADHD commercialized in Canada
DENVER, CO / ACCESSWIRE / October 1, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing ...
No comment yet